ArticleThoracic cancer2018

Presence of few PD-1-expressing tumor-infiltrating immune cells is a potential predictor of improved response to salvage chemotherapy following nivolumab for non-small cell lung cancer: An exploratory case series.

Daiki Ogawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.